Commerzbank AG
Commerzbank AG (CRZBY) Financial Performance & Income Statement Overview
Explore the financials of Commerzbank AG (CRZBY), including yearly and quarterly data on income, cash flow, and balance sheets.
Commerzbank AG (CRZBY) Income Statement & Financial Overview
Review Commerzbank AG CRZBY income statement with detailed quarterly and annual figures.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $5.87B | $7.15B | $5.41B | $6.74B |
Cost of Revenue | $2.81B | $3.03B | $3.28B | $3.37B |
Gross Profit | $3.06B | $2.74B | $2.13B | $3.37B |
Gross Profit Ratio | $0.52 | $0.38 | $0.39 | $0.50 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $0.00 | $2.48B | $36.00M | $36.00M |
Operating Expenses | $1.88B | $2.48B | $1.25B | $2.07B |
Total Costs & Expenses | $4.68B | $6.15B | $4.53B | $5.87B |
Interest Income | $4.88B | $5.11B | $5.33B | $5.45B |
Interest Expense | $2.81B | $3.03B | $3.28B | $3.37B |
Depreciation & Amortization | $0.00 | $0.00 | $0.00 | -$871.00M |
EBITDA | $1.19B | $996.00M | $884.00M | $870.00M |
EBITDA Ratio | $0.20 | $0.14 | $0.16 | $0.13 |
Operating Income | $1.19B | $1.63B | $884.00M | $870.00M |
Operating Income Ratio | $0.20 | $0.23 | $0.16 | $0.13 |
Other Income/Expenses (Net) | $0.00 | -$637.00M | -$3.00M | -$1.61B |
Income Before Tax | $1.19B | $996.00M | $884.00M | $870.00M |
Income Before Tax Ratio | $0.20 | $0.14 | $0.16 | $0.13 |
Income Tax Expense | $306.00M | $182.00M | $196.00M | $289.00M |
Net Income | $834.00M | $751.00M | $641.00M | $538.00M |
Net Income Ratio | $0.14 | $0.11 | $0.12 | $0.08 |
EPS | $0.73 | $0.61 | $0.54 | $0.45 |
Diluted EPS | $0.73 | $0.47 | $0.54 | $0.45 |
Weighted Avg Shares Outstanding | $1.14B | $1.15B | $1.18B | $1.19B |
Weighted Avg Shares Outstanding (Diluted) | $1.14B | $1.15B | $1.18B | $1.19B |
Financial performance has remained strong, with revenue growing from $6.74B in Q2 2024 to $5.87B in Q1 2025. Gross profit continued to perform well, with margins at 52% in the latest quarter. Operating income reached $1.19B in Q1 2025, holding a steady 20% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $1.19B. Net income rose to $834.00M, keeping EPS at $0.73. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan